Showing results (401-410 of 578) with videos related to
Sort By:
Pageof 58
The Journal of Clinical Endocrinology and Metabolism|March 1, 1996
Comparative study of alendronate versus etidronate for the treatment of Paget's disease of boneE Siris, R S Weinstein, R Altman, et al.Prehospital and Disaster Medicine|September 23, 2021
Prehospital Ketamine Administration for Excited Delirium with Illicit Substance Co-Ingestion and Subsequent Intubation in the Emergency DepartmentJoshua J Solano, Lisa M Clayton, Daniel J Parks, et al.Neurology|June 10, 2010
Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trialR T Naismith, L Piccio, J A Lyons, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2009
HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infectionMattia Bonsignori, M Anthony Moody, Robert J Parks, et al.American Journal of Physiology. Endocrinology and Metabolism|July 5, 2012
Selective cannabinoid-1 receptor blockade benefits fatty acid and triglyceride metabolism significantly in weight-stable nonhuman primatesVidya Vaidyanathan, Raul A Bastarrachea, Paul B Higgins, et al.The American Journal of Clinical Nutrition|October 15, 1998
Reduced oxidative susceptibility of LDL from patients participating in an intensive atherosclerosis treatment programE J Parks, J B German, P A Davis, et al.The Journal of Trauma and Acute Care Surgery|October 15, 2020
Does the Emergency Surgery Score predict failure to discharge the patient home? A nationwide analysisReem AlSowaiegh, Leon Naar, Ava Mokhtari, et al.Journal of Lipid Research|July 23, 2009
Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditionsMeenakshi Sundaram, Shumei Zhong, Maroun Bou Khalil, et al.Health Services Insights|July 28, 2025
The Impact of Hospital Affiliation on Hospital Transfer PracticesWardah Rafaqat, Omar Mahmud, Christopher Alba, et al.Hepatology (Baltimore, Md.)|October 21, 2019
Fatty Acid Synthase Inhibitor TVB-2640 Reduces Hepatic de Novo Lipogenesis in Males With Metabolic AbnormalitiesMajid M Syed-Abdul, Elizabeth J Parks, Ayman H Gaballah, et al.Pageof 58